Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,255 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,255 Papers indexed
1,440 Papers AI scored
40,255 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-09 10:15 AM
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40255 results
D
Unusual gastric localization of an inflammatory myofibroblastic tumor: A case report and review of the literature.
PMID 39270376 Published: 2024-09-10 Ingested: 2026-08-02 12:02 AM International journal of surgery case reports
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 30.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Infantile Cardiac Hemangioma: A Rare Case Presentation.
PMID 39267399 Published: 2024-09-12 Ingested: 2026-08-02 12:02 AM World journal for pediatric & congenital heart surgery
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

D
TRPV6 gene mutation associated with giant pancreatic pseudocyst with mediastinal extension in a pediatric patient: Lessons learned.
PMID 39266467 Published: 2024-09-12 Ingested: 2026-08-02 12:02 AM Journal of clinical ultrasound : JCU
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

D
Eyelid tumors in children over a 10-year period.
PMID 39257267 Published: 2024-08-31 Ingested: 2026-08-02 12:02 AM Folia medica
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 30.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Lack of classical astroblastoma features in pediatric MN1::BEND2-fused brain tumors.
PMID 39237118 Published: 2024-09-05 Ingested: 2026-08-02 12:02 AM Brain pathology (Zurich, Switzerland)
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

D
Suprasellar teratoma to germinoma recurrence: implications for diagnosis and follow-up.
PMID 39225727 Published: 2024-09-03 Ingested: 2026-08-02 12:02 AM Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 40.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

D
Micturition Hypertension in an Adolescent.
PMID 39157546 Published: 2024-08-07 Ingested: 2026-08-02 12:02 AM JACC. Case reports
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

D
A Rare Case of Infantile Myofibromatosis With Intra Cranial Involvement.
PMID 39157296 Published: 2024-08-15 Ingested: 2026-08-02 12:02 AM Global pediatric health
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

D
Childhood cancer surgery in low- and middle-income countries.
PMID 39099136 Published: 2024-08-04 Ingested: 2026-08-02 12:01 AM Pediatric blood & cancer
AI -
Standard 50.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 50.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

Previous
Page 2903 of 3355
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic